Key facts
- This page summarizes Michael Schreck's Form 3 filing for IDEXX LABORATORIES INC /DE (IDXX).
- 0 reported transactions and 13 derivative rows are listed below.
- Accepted by SEC: 05 Jan 2024, 17:02.
Michael Schreck - 01 Jan 2024 Form 3 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)
- Reporting relationship
- Executive Vice President
- Issuer ticker
- IDXX
- Reported as of
- 01 Jan 2024
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 05 Jan 2024, 17:02:13 UTC
- Next SEC filing
- 16 Feb 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael Schreck
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Michael Schreck filed Form 3 for IDEXX LABORATORIES INC /DE (IDXX) on 05 Jan 2024.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
IDXX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 535
- Date
- 01 Jan 2024
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
IDXX
holding
Derivative
Restricted Stock Unit
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Jan 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 164
- Exercise price
- Footnotes
- F1
IDXX
holding
Derivative
Restricted Stock Unit
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Jan 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 160
- Exercise price
- Footnotes
- F2
IDXX
holding
Derivative
Restricted Stock Unit
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Jan 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 352
- Exercise price
- Footnotes
- F3
IDXX
holding
Derivative
Restricted Stock Unit
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Jan 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 791
- Exercise price
- Footnotes
- F4
IDXX
holding
Derivative
Restricted Stock Unit
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Jan 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 678
- Exercise price
- Footnotes
- F5
IDXX
holding
Derivative
Restricted Stock Unit
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Jan 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,005
- Exercise price
- Footnotes
- F6
IDXX
holding
Derivative
Incentive Stock Option (right-to-buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Jan 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 744
- Exercise price
- $398.49
- Footnotes
- F7
IDXX
holding
Derivative
Non-Qualified Stock Option (right-to-buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Jan 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,769
- Exercise price
- $544.08
- Footnotes
- F8
IDXX
holding
Derivative
Incentive Stock Option (right-to-buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Jan 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 324
- Exercise price
- $544.08
- Footnotes
- F9
IDXX
holding
Derivative
Non-Qualified Stock Option (right-to-buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Jan 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,952
- Exercise price
- $505.53
- Footnotes
- F10
IDXX
holding
Derivative
Incentive Stock Option (right-to-buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Jan 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 197
- Exercise price
- $505.53
- Footnotes
- F11
IDXX
holding
Derivative
Non-Qualified Stock Option (right-to-buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Jan 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 4,765
- Exercise price
- $497.43
- Footnotes
- F12
IDXX
holding
Derivative
Incentive Stock Option (right-to-buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Jan 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 201
- Exercise price
- $497.43
- Footnotes
- F13
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 13 footnotes
Footnote F1
Grant of 659 restricted stock units ('RSU'). Each RSU represents a contingent right to receive one share of Issuer common stock and vest in four equal annual installments beginning on September 1, 2021.
Footnote F2
Grant of 322 RSUs. Each RSU represents a contingent right to receive one share of Issuer common stock and vest in four equal annual installments beginning on February 14, 2022.
Footnote F3
Grant of 470 RSUs. Each RSU represents a contingent right to receive one share of Issuer. common stock and vest in four equal annual installments beginning on February 14, 2023.
Footnote F4
Grant of 791 RSUs. Each RSU represents a contingent right to receive one share of Issuer common stock and vests in one installment on February 14, 2025.
Footnote F5
Grant of 678 RSUs. Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four equal annual installments beginning on February 14, 2024.
Footnote F6
Grant of 1,005 RSUs. Each RSU represents a contingent right to receive one share of Issuer common stock and vests in one installment on February 14, 2026.
Footnote F7
Grant of option to buy 744 shares of Issuer common stock that vests in four annual installments beginning on September 1, 2021.
Footnote F8
Grant of option to buy 2,769 shares of Issuer common stock that vests in four annual installments beginning on February 14, 2022.
Footnote F9
Grant of option to buy 324 shares of Issuer common stock that vests in one installment on February 14, 2025.
Footnote F10
Grant of option to buy 3,952 shares of Issuer common stock that vests in four annual installments beginning on February 14, 2023.
Footnote F11
Grant of option to buy 197 shares of Issuer common stock that vests in one installment on February 14, 2026.
Footnote F12
Grant of option to buy 4,765 shares of Issuer common stock that vests in four annual installments beginning on February 14, 2024.
Footnote F13
Grant of option to buy 201 shares of Issuer common stock that vests in one installment on February 14, 2027.